bioRxivBioinformaticsPreprint
Phylogeny-based selection of representative variants with Navargator: Proof of principle using humoral cross-reactivity data from two immunization studies
David M. CurraniD, Dixon NgiD, John ParkinsoniD, Trevor F. MoraesiD, Scott D. Gray‐OweniD, Jamie E. Fegan
- Citations
- 1
Abstract
BackgroundThe accessibility to the immune system of bacterial surface proteins makes them attractive targets for subunit vaccines. However, this same property also means they tend to exhibit high sequence variability. Achieving broad cross-protection usually necessitates that antigens from multiple isolates are included, but the choice of sequence variant is a non-trivial problem. Visual inspection of phylogenetic trees is the norm, but this is subjective and can be greatly influenced by the choice of viewing software. This has real-world implications, as groups have shown that the selection of non-optimal antigens likely led to lower cross-protection in the commercially available vaccines against Neisseria meningitidis serogroup B. Aim / MethodsTo address this problem, we have developed Navargator, bioinformatics software that takes a phylogenetic tree as input and identifies the variants that are the most similar to the greatest number of other sequences. The underlying premise is that cross-reactivity will be correlated with phylogenetic distances extracted from the tree; this was validated by several rodent immunization studies with the proteins transferrin-binding protein B and factor H binding protein from N. meningitidis and N. gonorrhoeae, measuring antibody-based cross-reactivity between an antigen panel using a custom high-throughput ELISA. ResultsNavargator has been made freely available both as an online tool and as source code for local installation. We implemented several different clustering methods, with exact algorithms for smaller datasets, and heuristics suitable for large trees of thousands of sequences. Our immunization studies have shown that this approach is sound, and that cross-reactivity is predicted well by phylogenetic distances in a sigmoidal manner. ConclusionsThe complexity of vaccine development rises sharply with each additional antigen included, so using the minimal number required is an important consideration. Navargator attempts to facilitate this in a systematic and generalizable manner. The user can run the analysis by selecting their desired number of representatives, or they can provide any form of cross-reactivity data and have the program identify a minimum reactivity threshold via correlation with the phylogenetic tree. The program will then identify the smallest number of representatives required to satisfy this threshold.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) Index: a Rapid and Accessible Tool that Exploits Genomic Data in Public Health and Clinical Microbiology Applications
Charlene M.C. Rodrigues, Keith A. Jolley, … Martin C. J. Maiden·Journal of Clinical MicrobiologyPeer-reviewed·Oct 15, 2020
- Rationally designed minimized TbpB confers broad protection against meningococcal infection
Epshita A. Islam, Jamie E. Fegan, … Scott D. Gray‐Owen·PLoS PathogensPeer-reviewed·Aug 10, 2026
- Neuraminidase-on-a-string nanoparticles probe how antigenic distance shapes elicited humoral immunity
Rochel Hecht, Faez Amokrane Nait Mohamed, … Aaron G. Schmidt·bioRxiv·Aug 21, 2025
- The breadth of protection mediated by anti-N2 neuraminidase antibody responses relies on cross-reactive and not cross-inhibiting antibodies
Laura Amelinck, Anouk Smet, … João Paulo Portela Catani·bioRxiv·Feb 4, 2026
- Design of a Streptococcus pyogenes M protein immunogen to elicit M type cross-reactivity
K.-C. Wang, E. Kuliyev, … P. Ghosh·bioRxiv·Dec 7, 2021
- Comparison of the neuraminidase antigenicity in recently circulating influenza A and vaccine viruses
J. Gao, X. Li, … R. Daniels·bioRxiv·May 21, 2021